Skip to content

Smoking Cessation Interventions in Stroke Patients

Comparison of Smoking Cessation Interventions of Different Intensities in Patients With First Ever Ischemic Stroke.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01574001
Enrollment
240
Registered
2012-04-10
Start date
2012-04-30
Completion date
2014-12-31
Last updated
2013-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Keywords

ischemic stroke, smoking cessation, antismoking interventions

Brief summary

The primary objective of the present randomized controlled trial is to compare the effectiveness of three anti-smoking interventions of different intensities. It has been hypothesised that early follow-up visits facilitate post-stroke smoking cessation in patients hospitalized because of first-ever ischemic stroke.

Detailed description

BACKGROUND: It is well known, that continued smoking after stroke increases the risk of death and stroke recurrence within a few years after the first stroke. Searching for more efficient methods of antismoking interventions is therefore justified. OBJECTIVES: The primary objective of the present study is to compare the effectiveness of three anti-smoking interventions of different intensities. DESIGN: Randomized, controlled trial. METHODS: Study participants will be recruited among patients of neurological clinics of Institute of Psychiatry and Neurology, hospitalized because of their first in a lifetime ischemic stroke. All stroke patients will be screened regarding their smoking status. The subjects will be patients smoking cigarettes immediately before their first-ever stroke, able to understand the research protocol procedures and able to cooperate during the investigation. Antismoking interventions will be based on the 5A's method. Study participants will be randomized to one of three interventions differing in follow-up intensity.

Interventions

BEHAVIORALAntismoking intervention with no early follow-up

an anti-smoking intervention in line with the 5A's method without early follow-up; follow-up assessment will be limited to two visits: 3 and 12 months after stroke

BEHAVIORALAntismoking intervention with minimal early follow-up

Anti-smoking intervention in line with the 5A's method (Ask, Advice, Assess, Assist, Arrange follow-up. The intervention will be carried out 5-7 days after stroke, before the planned discharge from the hospital. Seven days after discharge from a stroke unit a brief telephone/personal advice will be given aimed to motivate patients to quit smoking; follow-up assessment will include two visits: 3 and 12 months after stroke

BEHAVIORALAntismoking intervention with intensive early follow-up

an anti-smoking intervention in line with the 5A's method will be given, including four follow-up visits within 6 weeks after discharge from the hospital (week 1, week 2, week 4, week 6 after stroke); follow-up assessment will include two visits: 3 and 12 months after stroke

Sponsors

Institute of Psychiatry and Neurology, Warsaw
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients smoking immediately prior to stroke * The first in the lifetime ischemic stroke * Ability to understand the research protocol procedures and cooperation during the investigation * Reported availability of and declaration to participate in follow-up * Informed consent to participate in the study

Exclusion criteria

* Severe stroke * Stroke onset more than 3 weeks before admission * History of previous stroke with clinical symptoms * Hemorrhagic stroke * Diagnosis of dementia or presence of other neurological disease (Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, Huntington's chorea, a previous subarachnoid haemorrhage, meningitis, cerebral trauma in an interview)

Design outcomes

Primary

MeasureTime frame
Smoking cessation rate12 months

Countries

Poland

Contacts

Primary ContactHalina Sienkiewicz-Jarosz, M.D., PhD
jarosz@ipin.edu.pl+48224582548

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026